Overview

To Evaluate the Safety and Tolerability, Pharmacokinetics, Food-effect and Pharmacodynamics of EHP-101 in Healthy Volunteers

Status:
Completed

Trial end date:
2019-09-13

Target enrollment:

Participant gender:

Summary

The study will assess the safety and tolerability, pharmacodynamic, pharmacokinetic profiles, and food effect of single ascending doses and multiple ascending doses (7 consecutive days) after daily oral administration in healthy male and female subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Emerald Health Pharmaceuticals
Emerald Health Pharmaceuticals Inc.